To provide a comprehensive overview of USP19's molecular characteristics, physiological functions, disease-related mechanisms, and clinical translational potential.
Approach:
Review of USP19: The article systematically summarizes the role of USP19 in various health conditions, including malignancies and non-neoplastic diseases.
Mechanistic Research: It discusses the molecular mechanisms by which USP19 regulates protein stability, immune responses, and cellular stress.
Key Findings:
USP19 is involved in tumor proliferation, metastasis, apoptosis, immune evasion, and chemoresistance.
It shows aberrant expression in multiple malignancies and is associated with poor patient prognosis.
USP19 has a dual role, with overexpression in most tumors and protective upregulation in certain non-neoplastic diseases.
The gene is located at chromosome 3p21.3, a region often deleted in cancers, suggesting potential tumor-suppressive functions.
Interpretation:
USP19's diverse roles in health and disease highlight its potential as a diagnostic biomarker and therapeutic target.
Limitations:
The review does not provide clinical trial data or validated biomarkers for USP19.
It lacks a detailed exploration of the functional divergence between USP19 isoforms.
Conclusion:
USP19's regulatory mechanisms and expression patterns warrant further investigation.
Harold Burstein, MD, PhD, and Erica Mayer, MD, MPH discuss results from the TRAK-ER trial, which were presented at the 2026 ESMO Breast Cancer Congress.
